2014
DOI: 10.1016/j.toxac.2014.09.031
|View full text |Cite
|
Sign up to set email alerts
|

Nouvelles drogues de synthèse (NDS) et dépistage urinaire : une bonne connaissance des réactifs s’impose

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…It can be noted that Boland et al described also a positive result for their post-mortem case both in urine and gastric content with amphetamine EMIT Syva ® test [8]. Elsewhere, Swortwood et al described a high range of AMT crossreactivities (no response to 116%) among their 16 tested ELISA serum immunoassays with positive cut-off at either 3 piperazines and 7 other products), mainly amphetaminerelated chemical structures gave positive results [22]. These results suggest that efficient detection of new designer drugs cannot be performed using immunoanalysis and a chromatographic process either by LC-DAD or better by LC-MS/MS should be carried out.…”
Section: Discussionmentioning
confidence: 96%
“…It can be noted that Boland et al described also a positive result for their post-mortem case both in urine and gastric content with amphetamine EMIT Syva ® test [8]. Elsewhere, Swortwood et al described a high range of AMT crossreactivities (no response to 116%) among their 16 tested ELISA serum immunoassays with positive cut-off at either 3 piperazines and 7 other products), mainly amphetaminerelated chemical structures gave positive results [22]. These results suggest that efficient detection of new designer drugs cannot be performed using immunoanalysis and a chromatographic process either by LC-DAD or better by LC-MS/MS should be carried out.…”
Section: Discussionmentioning
confidence: 96%